Skip to content
Thursday, July 23, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Trump says US-Saudi nuclear deal subject to normalization with Israel July 23, 2026
  • Prize-winning journalist Amir Tibon is moving back to the kibbutz where he and his family survived Oct. 7 July 23, 2026
  • A Jerusalem cafe became a symbol of secular defiance — until Israelis learned it was run by Jews for Jesus July 23, 2026
  • The Inversion of History July 23, 2026
  • Reed College agrees to sweeping reforms as part of Title VI antisemitism settlement July 22, 2026
  • Israel alarmed by US-Saudi nuclear deal July 22, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.